title: Sialyltransferase activity and atherosclerosis.
authors.affiliation: From the Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom (A.P.S., Z.M.); and Institut National de la Santé et de la Recherche Médicale, Unit 970, Paris Cardiovascular Research Center, Paris, France (Z.M.).
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Sage
authors.forename: Ziad
authors.initials: Z
authors.lastname: Mallat
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000201:enzymology*; D018946:Chemokine CCL5 / Q000502:physiology*; D005260:Female; D036904:Leukocyte Rolling / Q000502:physiology*; D008297:Male; D022423:Myeloid Cells / Q000473:pathology*; D012799:Sialyltransferases / Q000172:deficiency*; D000094663:beta-Galactoside alpha-2,3-Sialyltransferase
chemical_list: C503460:Ccl5 protein, mouse; D018946:Chemokine CCL5; D012799:Sialyltransferases; D000094663:beta-Galactoside alpha-2,3-Sialyltransferase
keywords: CC chemokine receptors; CX3C chemokine receptors; CXC chemokine receptors; Editorials; atherosclerosis; chemokines; leukocytes